Pretreatment prostate-specific antigen as an outcome predictor of targeted transurethral microwave thermotherapy
Authors:
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasiaUrology, 1999
- Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasiaUrology, 1999
- Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trialUrology, 1999
- PROSPECTIVE RANDOMIZED COMPARISON OF HIGH ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY VERSUS alpha-BLOCKER TREATMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 1999
- PROSTATE SPECIFIC ANTIGEN DENSITY OF THE TRANSITION ZONE FOR EARLY DETECTION OF PROSTATE CANCERJournal of Urology, 1998
- A High-Efficiency Microwave Thermoablation System for the Treatment of Benign Prostatic Hyperplasia: Results of a Randomized, Sham-Controlled, Prospective, Double-Blind, Multicenter Clinical TrialUrology, 1998
- Transrectal Ultrasonography to Predict the Clinical Outcome of Transurethral Microwave Thermotherapy in Patients with Benign Prostatic HyperplasiaInternational Journal of Urology, 1996
- Responders and Nonresponders to Transurethral Microwave Thermotherapy: A Multicenter Retrospective AnalysisJournal of Urology, 1995
- Responders and Non-Responders to Treatment of Benign Prostatic Hyperplasia with Transurethral Microwave ThermotherapyScandinavian Journal of Urology and Nephrology, 1995
- Relationship between prostatc epithelial volume and serum prostate-specific antigen levelsUrology, 1994